Found: 22
Select item for more details and to access through your institution.
Novel Therapies to Address Unmet Needs in ITP.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 7, p. N.PAG, doi. 10.3390/ph15070779
- By:
- Publication type:
- Article
COVID-19 Vaccines and Autoimmune Hematologic Disorders.
- Published in:
- Vaccines, 2022, v. 10, n. 6, p. N.PAG, doi. 10.3390/vaccines10060961
- By:
- Publication type:
- Article
Avatrombopag plus fostamatinib combination as treatment in patients with multirefractory immune thrombocytopenia.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 4, p. 1551, doi. 10.1111/bjh.19602
- By:
- Publication type:
- Article
Use of eltrombopag after romiplostim in primary immune thrombocytopenia.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 1, p. 111, doi. 10.1111/bjh.13266
- By:
- Publication type:
- Article
Global Emerging HEmophilia Panel (GEHEP): A Multinational Collaboration for Advancing Hemophilia Research and Treatment.
- Published in:
- Transfusion Medicine & Hemotherapy, 2013, v. 40, n. 5, p. 352, doi. 10.1159/000354843
- By:
- Publication type:
- Article
The seasonal distribution of immune thrombotic thrombocytopenic purpura is influenced by geography: Epidemiologic findings from a multi‐center analysis of 719 disease episodes.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 11, p. 2063, doi. 10.1002/ajh.27458
- By:
- Publication type:
- Article
Successful use of thrombopoietin analogs in thrombocytopenia associated with MYH-9 mutation.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 11, p. 3283, doi. 10.1007/s00277-023-05386-0
- By:
- Publication type:
- Article
Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 17, p. 5117, doi. 10.3390/jcm13175117
- By:
- Publication type:
- Article
Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI).
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 20, p. 6422, doi. 10.3390/jcm12206422
- By:
- Publication type:
- Article
Real-World Rates of Bleeding, Factor VIII Use, and Quality of Life in Individuals with Severe Haemophilia A Receiving Prophylaxis in a Prospective, Noninterventional Study.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 24, p. 5959, doi. 10.3390/jcm10245959
- By:
- Publication type:
- Article
Efficacy and safety in patients with haemophilia A switching to octocog alfa (BAY 81–8973): Final results of the global real‐world study, TAURUS.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 1, p. 77, doi. 10.1111/ejh.13876
- By:
- Publication type:
- Article
BAY 81‐8973 prophylaxis and pharmacokinetics in haemophilia A: Interim results from the TAURUS study.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 164, doi. 10.1111/ejh.13420
- By:
- Publication type:
- Article
Prophylaxis therapy with bypassing agents in patients with haemophilia A and inhibitors undergoing surgery: A cost analysis in Spain.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 1, p. 94, doi. 10.1111/ejh.13414
- By:
- Publication type:
- Article
Spanish consensus guidelines on prophylaxis with bypassing agents for surgery in patients with haemophilia and inhibitors.
- Published in:
- European Journal of Haematology, 2016, v. 96, n. 5, p. 461, doi. 10.1111/ejh.12730
- By:
- Publication type:
- Article
Sustained Remission in Patients with Primary Immune Thrombocytopenia after Romiplostim Tapering and Discontinuation: A Case Series in Real Life Management in Spain.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Hip Replacement Surgery in 14-Year-Old Girl with Factor V Deficiency: Haemostatic Treatment and Thromboprophylaxis.
- Published in:
- Case Reports in Hematology, 2016, p. 1, doi. 10.1155/2016/5024692
- By:
- Publication type:
- Article
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 3, p. E40, doi. 10.1002/ajh.23900
- By:
- Publication type:
- Article
Acquired Haemophilia A: A Review of What We Know.
- Published in:
- Journal of Blood Medicine, 2022, v. 13, p. 691, doi. 10.2147/JBM.S342077
- By:
- Publication type:
- Article
Humanistic burden of haemophilia A without inhibitors: A cross‐sectional analysis of the HemoLIFE study.
- Published in:
- Haemophilia, 2024, v. 30, n. 4, p. 950, doi. 10.1111/hae.15057
- By:
- Publication type:
- Article
Type 2N VWD: Conclusions from the Spanish PCM‐EVW‐ES project.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 1007, doi. 10.1111/hae.14405
- By:
- Publication type:
- Article
Ultrasound evaluation of joint damage and disease activity in adult patients with severe haemophilia A using the HEAD‐US system.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 479, doi. 10.1111/hae.14280
- By:
- Publication type:
- Article
Adherence to prophylaxis in adult patients with severe haemophilia A.
- Published in:
- Haemophilia, 2020, v. 26, n. 5, p. 800, doi. 10.1111/hae.14039
- By:
- Publication type:
- Article